CVC BRASIL (CVCB3) Main Indicators
Basic Data - CVCB3
| Company | CVC BRASIL |
| Corporate Name | CVC BRASIL OPERADORA E AGÊNCIA DE VIAGENS S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Serviços de turismo. compreendendo a intermediação. individualmente ou na forma agregada. de passagens aéreas. transporte terrestre. reservas de hotéis. passagens de cruzeiros marítimos. entre outros. |
| Share | CVCB3 |
| Quote Date | 04/02/2025 |
| Share Type | ON |
| Last Closing | R$ 2.12 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 69.71 M |
| Last Statement | DFP - 12/31/2024 |
| Sector | Consumo Cíclico |
| Subsector | Viagens e Lazer |
| Segment | Viagens e Turismo |
| Participation Indexes | IBOVESPA, IBRA, IBRX, ICON, IGC, IGCT, IGNM, ITAG, SMLL |
| Updated 04/03/2025 | |
Relative Prices - CVCB3
| Price/Earnings | -10.78 |
| Price/SBV | 2.10 |
| Price/Net Sales | 0.78 |
| Price/CFO | 2.91 |
| Price/FCF | 2.94 |
| Price/Total Assets | 0.29 |
| Price/EBIT | 12.27 |
| Price/Working Capital | -3.66 |
| Price/NCAV | -0.31 |
| EV/EBIT | 13.83 |
| EV/EBITDA | 4.01 |
| EV/Net Sales | 0.88 |
| EV/CFO | 3.28 |
| EV/FCF | 3.32 |
| EV/Total Assets | 0.33 |
| Company Market Cap | R$ 1.11 B |
| Enterprise Value | R$ 1.26 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 2.12 |
| Share Price Date | 04/02/2025 |
| Dividend Yield | 0.00% |
| Updated 04/03/2025 | |
Income Statement - CVCB3
| Net Revenue | R$ 1.42 B |
| Gross Result | R$ 1.31 B |
| EBIT | R$ 90.82 M |
| Depreciation and Amortization | - R$ 222.50 M |
| EBITDA | R$ 313.32 M |
| Net Profit | - R$ 103.34 M |
| Net Profit/Share | - R$ 0.20 |
| Updated 03/26/2025 | |
| Net Revenue | R$ 375.14 M |
| Gross Result | R$ 356.42 M |
| EBIT | R$ 13.76 M |
| Depreciation and Amortization | - R$ 58.88 M |
| EBITDA | R$ 72.64 M |
| Net Profit | - R$ 61.23 M |
| Profit/Share | - R$ 0.12 |
| Updated 03/26/2025 | |
Price and Volume Behavior - CVCB3
| Lowest Price 52 weeks | R$ 1.38 |
| Highest Price 52 weeks | R$ 2.84 |
| Variation 2025 | 41.33% |
| Variation 1 year | -21.19% |
| Variation 2 years(total) | -31.83% |
| Variation 2 years(yearly) | -17.37% |
| Variation 3 years(total) | -87.42% |
| Variation 3 years(yearly) | -49.83% |
| Variation 4 years(total) | -88.99% |
| Variation 4 years(yearly) | -42.36% |
| Variation 5 years(total) | -79.32% |
| Variation 5 years(yearly) | -27.02% |
| Average Daily Volume (3 months) | R$ 37.76 M |
| Updated 04/03/2025 | |
Returns and Margins - CVCB3
| Return on Initial Tangible Capital | 18.73% |
| Return on Initial Invested Capital | 6.55% |
| Pre-Tax Return on Initial Tangible Capital | 28.37% |
| Pre-Tax Return on Initial Invested Capital | 9.92% |
| Return on Initial Shareholder´s Equity | -17.00% |
| Return on Initial Asset | -2.56% |
| Gross Margin | 92.54% |
| Net Margin | -7.27% |
| EBIT Margin | 6.39% |
| EBITDA Margin | 22.05% |
| Initial Asset Turnover | 0.35 |
| Financial Leverage | 7.22 |
| Liabilities/Net Worth | 6.22 |
| Net Debt/EBITDA | 0.45 |
| Updated 03/26/2025 | |
Balance Sheet - CVCB3
| Cash and Cash Equivalents | R$ 400.23 M |
| Total Assets | R$ 3.84 B |
| Short-Term Debt | R$ 9.45 M |
| Long-Term Debt | R$ 532.87 M |
| Gross Debt | R$ 542.32 M |
| Net Debt | R$ 142.09 M |
| Shareholder´s Equity | R$ 531.63 M |
| Share Book Value | R$ 1.01 |
| Common Shares | 525,591,097 |
| Preferred Shares | 0 |
| Total | 525,591,097 |
| Common Shares in Treasury | 8,326 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 8,326 |
| Common Shares (Except Treasury) | 525,582,771 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 525,582,771 |
| Updated 03/26/2025 | |
Cash Flow - CVCB3
| Operating Cash Flow | R$ 382.45 M |
| Cash Flow from Investments | - R$ 86.64 M |
| Financing Cash Flow | - R$ 410.22 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 82.60 M |
| Updated 03/26/2025 | |
| Operating Cash Flow | R$ 217.23 M |
| Cash Flow from Investments | - R$ 10.47 M |
| Financing Cash Flow | - R$ 213.22 M |
| Increase (Reduction) in Cash and Equivalents | R$ 16.79 M |
| Updated 03/26/2025 | |
Experimental - CVCB3
| CAPEX 3 months | - R$ 607.00 thousand |
| Free Cash Flow 3 months | R$ 216.62 M |
| CAPEX 12 months | - R$ 3.76 M |
| Free Cash Flow 12 months | R$ 378.70 M |
| Updated 03/26/2025 | |